Table 4.
Univariate hazards model of survival according to clinicopathological characteristics
| HR (95% CI) | p-value | |
|---|---|---|
| Vascular changes | ||
| Any vascular lesions | 3.89 (0.49–31.09) | 0.2 |
| Arteriolar wall thickening | 5.76 (0.72–46.2) | 0.1 |
| Fibrous intimal thickening | 1.37 (0.37–5.15) | 0.6 |
| Pathological Features | ||
| Global glomerulosclerosis | 1.05 (1.03–1.07) | 0.00006* |
| Clinical Information | ||
| Age | 1.05 (0.99–1.1) | 0.067 |
| eGFR | 0.93 (0.9–0.97) | 0.0004* |
| UPCR | 1.15 (0.96–1.37) | 0.13 |
| BUN | 1.14 (1.08–1.21) | 0.000003* |
| Serum creatinine | 3.264 (2.12–5.03) | 0.00000009* |
| Albumin | 0.37 (0.17–0.81) | 0.013* |
| Duration of hypertension prior to biopsy | 1 (0.99–1.01) | 0.58 |
| Duration of kidney injury prior to biopsy | 0.99 (0.97–1.01) | 0.31 |
HR, hazard ratio; CI, confidence interval; eGFR, estimated glomerular filtration rate; UPCR, urine protein-to-creatinine ratio; BUN, blood urea nitrogen.